Search

Objective: To investigate the influence of the dead space in disposable blood sampling needle on activated partial thromboplastin time (APTT), FVIII level and pharmacokinetic (PK) profiles in children with hemophilia. Methods: Children (<18 years) with severe hemophilia A were enrolled. After three days' washout-period, blood samples were collected at pre-dose, 1 h, 3 h, 9 h, 24 h and 48 h post-infusion. At each timepoint, two 2 mL vacuum tubes with 3.2% trisodium citrate were used. The first tube was signed as 'non-standard' (NS) and the second tube was signed as 'standard' (S). FVIII activities were evaluated by one-stage assay. WAPPS-Hemo was used to generate PK profiles like half-life time (t1/2), clearance (CL), trough level and time to 1, 2 and 5IU/dL after a dose of 50 ± 10IU/dL. The FVIII activities at 9 h and 24 h post-infusion were put into WAPPS and thus brought four combinations by true or biased FVIII level that used. Result: Compared with standard-collected blood samples, prolonged APTT results (P-values < 0.01) and decreased FVIII activity (P-values < 0.05) were revealed in those non-standard blood samples. The corresponding bias was in positive relation to both APTT-S (r = 0.44, P < 0.0001) and FVIII-S level(r = 0.68, P < 0.001). The FVIII bias percentage got larger as FVIII-S level reduced (r = −0.24, P < 0.01). During the four combinations of FVIII activity at 9 h and 24 h, statistically longer t1/2, lower CL and longer time to 1, 2 or 5IU/dL were observed in 9H-S&24H-S group and 9H-NS&24H-S group. Conclusion: While using vacuum tubes for clotting indicators and PK profiles, the dead space of blood sampling needle should be eliminated in advance. [ABSTRACT FROM AUTHOR]

Importance: Emicizumab (EMI) is efficacious and safe for hemophilia A (HA) prophylaxis. However, its high cost poses a challenge in China. Objective: To explore the possibility of using reduced‐dosage EMI in Chinese HA children. Methods: We conducted a retrospective study for HA children in our Comprehensive Care Center. Data were collected pre‐ and post‐EMI treatment to evaluate bleeding rates. Laboratory analyses included factor VIII (FVIII)‐like activity and EMI concentration measurements. Results: Thirty‐four HA children receiving EMI prophylaxis for a median (range) 24.5 (2.5–47.9) months by June 2023. Of these, 25 (73.5%) were under 3 years of age, 26 (76.5%) had severe hemophilia and 12 (35.3%) were minimally treated or previously untreated patients. Thirty‐one (91.2%) of the 34 patients received reduced‐dosage EMI for economic reasons. EMI concentration and FVIII‐like activity measured showed a strong correlation. Overall, while on EMI, their annual treated bleeding rate (ATBR) and annual bleeding rate (ABR) decreased significantly (2–0) while their zero‐bleeding rate (ZBR) increased significantly (11.5%–65.4%). After 6 months of EMI, there was no significant difference in ATBR and ABR among various maintenance dosages. However, ZBR was significantly lower in dosages under 4 mg/kg (P = 0.0156). Receiver operator characteristic curves suggested the following cutoff values for zero bleeding: EMI 4‐weekly maintenance dosage 3.8 mg/kg, EMI concentration 48.1 μg/mL, and FVIII‐like activity 15.4 IU/dL. Interpretation: We showed EMI effectively prevented bleeding even at reduced dosages. However, the bleeding risk may be higher with EMI 4‐weekly maintenance dosage <3.8 mg/kg, EMI concentration <48.1 μg/mL, and FVIII‐like activity <15.4 IU/dL for zero bleeding. It is important that dosage reduction be done rationally. Dosage tailoring is possible. [ABSTRACT FROM AUTHOR]

Summary: There are variations in individual eltrombopag concentrations that may impact efficacy and adverse drug reactions (ADRs) in paediatric immune thrombocytopenia (ITP). To solve this problem, we tailored the eltrombopag dosage refer to concentration, then followed up to assess concentration value in paediatric ITP. This is a single‐centre, prospective, observational study. The eltrombopag dosage was adjusted, and children were divided into three groups: the maintenance, discontinuation, and increase groups. Concentration and other data were compared to explore concentration value in guiding the individualized treatment of paediatric ITP. Thirty‐nine patients were enrolled, including 23 in the maintenance group, 3 in the discontinued group and 13 in the increase group. 3 patients discontinued eltrombopag due to ADRs, which was significantly higher than patients in the maintenance group (t = 3.606, p = 0.001). In all, 13 patients increased their dosage due to poor response, whose concentration and platelet count were significantly lower than patients in the maintenance group (t = 2.461, p = 0.019; t = 4.633, p < 0.001). Two months after the increase, the number of patients reaching CR and R respectively increased by 2 and 3, while the median platelet count was significantly raised (Z = −2.411, p = 0.016). Concentration could be used as a reference index for the individualized treatment of eltrombopag in paediatric ITP. [ABSTRACT FROM AUTHOR]

Summary: Chronic refractory primary immune thrombocytopenia (CRITP) is currently defined as refractory to multiple therapeutic of second‐line agents with or without splenectomy, faced with the threat of severe bleeding and challenging to obtain effective treatment. Although stable and effective drug therapy is needed, it is tough to find one. Daratumumab (Dara), an anti‐CD38 monoclonal antibody presented the target cloned plasma cells in multiple myeloma, has also been reported to be effective in refractory autoimmune cytopenia in some case or series reports and ongoing clinical trials for adult patients with CRITP. Here, we report the early and durable response of Dara combination with avatrombopag in three CRITP patients (2 male and 1 female aged 12, 5 and 7 years, respectively) in our centre, with a follow‐up period of more than 25 weeks. Before Dara, the duration of immune thrombocytopenia was 9, 1.4 and 4 years, respectively, a baseline platelet count of 4, 6, 9 × 109/L, the bleeding score was all above level 2 and the number of previous drugs was >3. The time to response (R: Plt ≥30 × 109/L with at least a twofold increase in the baseline count) of Dara was on Day 45, 6 and 4 and achieved complete response (CR: Plt ≥100 × 109/L) on Day 51, 6 and 8, the sustained response (SR: Plt >30 × 109/L following Dara at ≥75% of the platelet count assessment at follow‐up end‐point since the patient achieved response) was 48, 175 and 204 days with the follow‐up time of 39.1, 25.9 and 29.7 weeks. The bleeding score decreased from grade 3 to grade 0 during follow‐up. No significant treatment‐related adverse events were found during follow‐up. Dara combination with avatrombopag may be a safe and efficacious therapy for children with CRITP, but it needs to be further explored. [ABSTRACT FROM AUTHOR]

Immune thrombocytopenia (ITP) is an autoimmune-mediated hemorrhagic disease. Emerging evidence indicates that FOXO1 SNPs are related to the immune dysregulation of several autoimmune diseases suggesting that FOXO1 may be involved in inflammation and pathologic activities in patients with ITP. This study aimed to evaluate whether FOXO1 gene single-nucleotide polymorphisms (SNPs) are associated with susceptibility to ITP and clinical priorities of concern include bleeding severity and sensitivity of glucocorticoid treatment. This study recruited 327 newly diagnosed ITP and 220 healthy controls. Four SNPs (rs17446593, rs17446614, rs2721068, and rs2721068) of the FOXO1 gene were detected using the Sequenom MassArray system. Bleeding severity were classified into the mild and severe groups based on the bleeding scores. ITP patients were classified as sensitive and insensitive to glucocorticoid treatment according to the practice guideline for ITP (2019 version). The frequencies of the four SNPs did not show any significant differences between the ITP and healthy control groups. Patients with AA genotype at rs17446593 (p = 0.009) and GG genotype at rs17446614 (p = 0.009) suffered more severe bleeding than patients without them. Carriers of haplotype Grs17446593Ars17446614Crs2721068Trs2755213 were protective to severe bleeding (p = 0.002). The AA genotype at rs17446593 was significantly higher in ITP patients sensitive to glucocorticoid treatment than in those insensitive to glucocorticoid treatment (p = 0.03). Haplotype Grs17446593Grs17446614Trs2721068Trs2755213 increases the risk of glucocorticoid resistance (p = 0.007). Although FOXO1 gene polymorphisms were not associated with susceptibility to ITP, the AA genotype at rs17446593 and GG genotype at rs17446614 were associated with bleeding severity. Haplotype GACT have a protective effect against severe bleeding. Patients with AA genotype at rs17446593 may tend to have good responds to glucocorticoid treatment. However, the FOXO1 gene haplotype GGTT increases the risk of glucocorticoid-resistant. Trial registration: ChiCTR1900022419. [ABSTRACT FROM AUTHOR]

Importance: It remained unclear that the efficacy comparison between low‐dose immune tolerance induction (LD‐ITI) incorporating immunosuppressants (IS) when severe hemophilia A (SHA) patients had inhibitor‐titer ≥200 Bethesda Units (BU)/mL (LD‐ITI‐IS200 regimen) and LD‐ITI combining with IS when SHA patients had inhibitor‐titer ≥40 BU/mL (LD‐ITI‐IS40 regimen). Objective: To compare the efficacy of the LD‐ITI‐IS200 regimen with that of the LD‐ITI‐IS40 regimen for SHA patients with high‐titer inhibitors. Methods: A prospective cohort study on patients receiving LD‐ITI‐IS200 compared to those receiving LD‐ITI‐IS40 from January 2021 to December 2023. Both received LD‐ITI [FVIII 50 IU/kg every other day]. IS (rituximab + prednisone) was added when peak inhibitor tier ≥200 BU/mL in the LD‐ITI‐IS200 regimen and ≥40 BU/mL in the LD‐ITI‐IS40 regimen. Success is defined as a negative inhibitor plus FVIII recovery ≥66% of the expected. Results: We enrolled 30 patients on LD‐ITI‐IS200 and 64 patients on LD‐ITI‐IS40, with similar baseline clinical characteristics. A lower IS‐use rate was discovered in the LD‐ITI‐IS200 regimen compared to the LD‐ITI‐IS40 regimen (30.0% vs. 62.5%). The two regimens (LD‐ITI‐IS200 vs. LD‐ITI‐IS40) had similar success rate (70.0% vs. 79.7%), median time to success (9.4 vs. 10.6 months), and annualized bleeding rate during ITI (3.7 vs. 2.8). The cost to success was lower for LD‐ITI‐IS200 than for LD‐ITI‐IS40 (2107 vs. 3256 US Dollar/kg). Among patients with peak inhibitor‐titer 40–199 BU/mL, 10 non‐IS‐using (on LD‐ITI‐IS200 regimen) and 28 IS‐using (on LD‐ITI‐IS40 regimen) had similar success rates (70.0% vs. 78.6%) and time to success (9.0 vs. 8.8 months). Interpretation: In LD‐ITI, IS are not necessary for inhibitor titer <200 BU/mL. [ABSTRACT FROM AUTHOR]

Owing to their high intrinsic safety, dispersed fuel particles are an important fuel pattern for fourth-generation nuclear reactors. Due to the unique cladding layers and the random dispersion characteristics, dispersed fuel particles significantly differ from pressurized water reactors regarding operation-induced uncertainty. This study quantitatively analyzed overall uncertainty while considering a random distribution of dispersed fuel particles, material thickness, and fuel enrichment. The results demonstrated that, for all packing fractions, the uncertainty induced by the random dispersion of dispersed fuel particles was below 0.03%. For every packing fraction, the differences between the results obtained by the regular and the random distribution models increased, and then decreased, until reaching its maximum (1.297%) at 15%. Keff decreased as the radius of the UO2 kernel increased; Keff increased as the thickness of the cladding layer increased; the uncertainty of Keff was 1.003% when a random distribution of particles, material thickness, and fuel enrichment were taken into consideration; the uncertainty of the power distribution of reactor core assemblies was maximized (1.495%) at the edge of the reactor core. Quantitative analysis of uncertainty provides references for the optimization of design and safety margin analysis for reactors. [ABSTRACT FROM AUTHOR]

Summary: Avatrombopag (AVA) is a novel thrombopoietin receptor agonist (TPO‐RA) that has been recently approved as a second‐line therapy for immune thrombocytopenia (ITP) in adults; however, its safety and efficacy data in children are lacking. Here, we demonstrated the efficacy and safety of AVA as second‐line therapy in children with ITP. A multicentre, retrospective, observational study was conducted in children with persistent or chronic ITP who did not respond to or relapsed from previous treatment and were treated with AVA for at least 12 weeks between August 2020 and December 2022. The outcomes were the responses (defined as achieving a platelet count ≥30 × 109/L, twofold increase in platelet count from baseline and absence of bleeding), including rapid response within 4 weeks, sustained response at weeks 12 and 24, bleeding control and adverse events (AEs). Thirty‐four (18 males) patients with a mean age of 6.3 (range: 1.9–15.3) years were enrolled. The median number of previous treatment types was four (range: 1–6), and 41.2% patients switched from other TPO‐RAs. Within 4 weeks, overall response (OR) was achieved in 79.4% patients and complete response (CR, defined as a platelet count ≥100 × 109/L and the absence of bleeding) in 67.7% patients with a median response time of 7 (range: 1–27) days. At 12 weeks, OR was achieved in 88.2%, CR in 76.5% and sustained response in 44% of patients. At 24 weeks, 22/34 (64.7%) patients who achieved a response and were followed up for 24 weeks were evaluated; 12/22 (54.55%) achieved a sustained response. During AVA therapy, median platelet counts increased by week 1 and were maintained throughout the treatment period. The proportion of patients with grade 1–3 bleeding decreased from 52.95% at baseline to 2.94% at 12 weeks, while concomitant ITP medications decreased from 36.47% at baseline to 8.82% at 12 weeks, with only 9 (26.47%) patients receiving rescue therapy 23 times within 12 weeks. There were 61.8% patients with 59 AEs: 29.8% with Common Terminology Criteria for Adverse Events grade 1 and the rest with grade 2. These findings show that AVA could achieve a rapid and sustained response in children with persistent or chronic ITP as a second‐line treatment, with good clinical bleeding control and reduction of concomitant ITP therapy, without significant AEs. [ABSTRACT FROM AUTHOR]

Summary: We have previously confirmed the efficacy and safety of eltrombopag (ELT) in children with chronic immune thrombocytopenia (cITP). However, data on both long‐term exposure and early use of TPO‐RAs are lacking, so further 'field‐practice' evidence on treatment is required. Here, we report the long‐term follow‐up results (between September 2018 and June 2023) of our previous study. The main objective of this study was to retrospectively review our large institutional experience with ITP patients previously enrolled in our paediatric cITP study. We had more than 3 years of follow‐up by June 2023 for treatment patterns and outcomes. A total of 65 patients (28 males) were enrolled, with a median age at ELT initiation of 6.34 (range 1.65, 14.13) years and a follow‐up of 47.07 (36.00, 57.00) months, with 40.36 (10.53, 56.83) months of ELT therapy at the time of analysis. In total, 29.23% (19/65) of patients discontinued ELT due to stable response, and 18.46% (12/65) of patients switched to other ITP therapies due to loss of response (LOR) after 19.13 (14.53, 26.37) months. Of the 19 patients who discontinued ELT due to a stable response, 24.62% (16/65) achieved a 12 m sustained response off‐treatment (SRoT); the last recorded platelet count ranged from 56 to 166 × 109/L (median 107 × 109/L); and 4.62% (3/65) patients relapsed at 5, 6 and 9 months after discontinuation. Of the 12 patients who LOR to ELT after 19.13 (14.53, 26.37) months of therapy, four switched to avatrombopag, three switched to hetrombopag, two switched to traditional Chinese medicine (TCM), one underwent splenectomy and two received additional prednisolone under ELT treatment. Thirty‐four patients who tapered and maintained a durable response. The patients with LOR and the patients with tapering were compared; the platelet count at the start of ELT is lower, and the time to response is longer in the patients with LOR. The platelet count at the start of ELT and the time to response may be the predictive factors for LOR during ELT treatment. We report more than 3 years of long‐term clinical data on children with cITP using ELT. These data do not raise any new safety concerns regarding the long‐term use of ELT in children with cITP. [ABSTRACT FROM AUTHOR]

Summary: The thrombopoietin receptor agonists (TPO‐RA) were recommended for primary immune thrombocytopenia (ITP) during the pandemic of COVID‐19. However, the incidence of thrombocytosis and thrombosis was sporadically reported in the chronic immune thrombocytopenia (CITP) patients receiving TPO‐RA during the COVID‐19 infection. With the local prevalence of COVID‐19 in December 2022 in the Beijing area, we got more powerful evidence about the change in platelet (Plt) counts associated with COVID‐19 infection. A single‐centre observational cohort study was performed from the beginning of December 2022 to the end of February 2023 to enrol CITP children treated with TPO‐RA alone as the second‐line treatment and suffering from the COVID‐19 infection in December 2022. The Plt counts before, during and after COVID‐19 infection were collected. In total, 67 (34 males and 33 females) patients with 8.10 (2.15, 15.70) years of age were enrolled. Sixty‐three patients who had responded to the TPO‐RA showed a transient increase in Plt counts after the infection of COVID‐19. The time of starting to increase was on Day 3 (2, 7), and to the peak level on Day 14 (7, 19) of infection with the peak Plt count was 289 (88, 1974) × 109/L. With at least 2 months observation period from COVID‐19 infection, the Plt counts of 100% (63/63) patients declined to the baseline on Day 25 (14, 41). The phenomenon of transient increase in Plt counts has been shown in the CITP children who responded to TPO‐RA when suffering from COVID‐19 infection. [ABSTRACT FROM AUTHOR]

The impacts of Li+ replacement for Mn2+ on the structure, vacancy defects, and magnetic and dielectric characteristics of Mn1-xLixWO4 (x = 0.00–0.20) ceramics synthesized by solid-state reaction were investigated. The analysis of XRD and Raman results revealed that Mn1-xLixWO4 samples had single-phase monoclinic structure, and Li+ ions had partially replaced Mn2+ ions and induced lattice deformation and substitutional disorder in Mn1-xLixWO4. Positron annihilation lifetime spectroscopy indicated that Li+ replacement resulted in the reduction of vacancy size and the increase of vacancy concentration. The dielectric properties measurements showed that Li+ replacement significantly enhanced the dielectric constant of the Mn1-xLixWO4 samples. It could be observed from the magnetic properties measurements that Li+ replacement suppressed the AF1 phase, extended the existing temperature range of AF2 phase, and weaken the magnetization of Mn1-xLixWO4 system. The evolution of magnetic properties was related to vacancy defects, lattice distortion, chemical disorder, and magnetic dilution effect caused by Li+ replacement. [ABSTRACT FROM AUTHOR]

Objectives: To assess current treatment‐related outcomes for children with severe and moderate haemophilia A (cHA) in China. Methods: This cross‐section Patient Report Outcome (PRO) report collected PRO data of severe and moderate cHAs registered in the 'Hemophilia Home Care Center' database (http://web.bjxueyou.cn) between January 2021 and November 2022. Data included records of bleeding, activities, and concentrates consumption. All patients had a confirmed diagnosis of moderate or severe haemophilia A (FVIII: C ≤ 5%) and were < 18 years old. Results: Among 1038 analysable cases, 9.6% of children with inhibitors had a higher rate of intracranial haemorrhage, dropout school rate, and higher FVIII consumption than children without inhibitors. Among 100 children with inhibitors, 36 patients were treated without immune tolerance induction (ITI), 14 patients with irregular treatment and 50 patients received ITI. Children with ITI had a lower ABR (2.4 (0,6.6) vs. 13.4 (9.5, 26.6), p<.001) and AJBR (0 (0, 3.1) vs. 8.9 (1.6, 19.3), p <.001) compared to those without ITI. Among 938 children without inhibitors, 28.5% received on‐demand treatment and 71.5% received prophylaxis. Of 528 children with 1343.8 (1050.4, 2922.9)IU/kg/year median FVIII consumption, 43.0% received low‐dose, 43.2% received intermediate‐dose, and 13.8% received high‐dose regimen; these children with prophylaxis had a lower ABR (3.1 (0, 10.7) vs. 12.8 (2.4, 45.5), p <.001), AJBR (0.5 (0, 3.9) vs. 3.0 (0, 12.0), p <.001) and disability rate (9.0% vs.18.5%, p =.032) compared to children who received on‐demand treatment. Conclusion: The high rate of drop‐out of school and disability still present a huge gap to meet the needs in China. It is necessary to improve the level of medical accessibility and medicine affordability and strengthen the patient/parent's education in China. [ABSTRACT FROM AUTHOR]

In wireless sensor networks, terminal devices with restricted cost and size have limited battery life. Meanwhile, these energy-constrained devices are not easy to access, especially when the terminal devices are located in severe environments. To recharge the energy-constrained devices and extend their network service time, unmanned aerial vehicles (UAVs) equipped with wireless power chargers are leased by the third-party control center. To incent the participation of UAVs with different charging capabilities and ensure the strategy-proofness of the incentive mechanism, a hidden information based contract theory model, specifically adverse selection, is introduced. By leveraging individual rationality and incentive compatibility, a contract theory based optimization problem is then formulated. After reducing redundant constraints, the optimal contract items are derived by Lagrangian multiplier. Finally, numerical simulation results are implemented to compare the prepared algorithm with three other baselines, which validates the effectiveness of our proposed incentive mechanism. [ABSTRACT FROM AUTHOR]

Summary: Eltrombopag (ELT) is effective and safe in adult persistent/chronic immune thrombocytopenia (p/cITP); a proportion could achieve a sustained response off treatment (SRoT); however, data on children are lacking. We attempted to analyse SRoT of ELT in children with p/cITP in this study. A multicentre retrospective observational study was performed in November 2022 for children with p/cITP who used ELT alone for >2 months between January 2017 and November 2021. Clinical data of pre‐, during and post‐ELT were collected. SRoT was defined as maintaining a platelet count of ≥30 × 109/L without rescue therapy for at least 6 months off ELT. There were 143 patients enrolled; 69.2% (99/143) achieved an overall response of 43.3% and 25.9% achieved complete response (CR) and response (R). Among the 35 patients analysed from whom ELT was withdrawn, 71.4% (25/35) showed SRoT after discontinuing ELT without additional ITP therapy, with a median follow‐up of 0.94 (range, 0.53–3.8) years, equal to 17.5% (25/143) in all patients treated with ELT. Compared with the patients with relapse (n = 10), the SRoT patients (n = 25) had a higher rate of CR (80% [20/25] vs. 40% [4/10]), shorter interval time from initiation to taper (6.4 months vs. 9.4 months), longer time from taper to withdrawal (1.1 years vs. 0.3 years) and a longer duration of ELT treatment (1.6 years vs. 0.5 years) with p < 0.05. Patients who achieved CR could attain SRoT more easily (p = 0.02). ELT had a response in 69.2% of children with p/cITP and 17.5% of them attained SRoT with good tolerance. The patients who achieved CR and began ELT treatment as early as possible, with a longer treatment duration and slower tapering, had a higher probability of SRoT. [ABSTRACT FROM AUTHOR]

Vehicle platooning can significantly increase throughput of transportation, while the impairment of communication may affect the control performance of vehicle platooning. Communication delays are inevitable in the process of driving, which will cause the instability of the platoon. Moreover, the transmission power level between vehicles is finite, resulting in a limited communication range. A nonlinear control algorithm is proposed where the car-following interactions between vehicles are considered. First, a third-order heterogeneous dynamic model is established for vehicles in the platoon. The control gains and parameters are heterogeneous. Then considering the constant time headway spacing policy and the gap supplement, conditions of the control gains for maintaining the internal stability of the platoon are obtained. Second, with time-varying communication delays taken into account, the allowed upper bound of communication delays is derived. Third, given the ability of each vehicle to receive information from multiple predecessors and followers, conditions of string stability are obtained, where the communication range is limited. Finally, numerical simulations are conducted to demonstrate the effectiveness of the proposed controller. [ABSTRACT FROM AUTHOR]

Owing to the wide distribution of rural areas, the construction of power facilities is not perfect, which poses a great challenge to the power supply stability of the rural power grid. As an important supplement, the microgrid (MG) plays a complementary role in improving the power supply quality. However, the addition of the MG increases the complexity, and how to balance the interests of the participants has become a substaintial problem. Based on the analysis of the power consumption characteristics of rural residential, agricultural and industrial areas, a game relationship model between MG operators and power users is established, and the overall optimal strategy is obtained in this paper. For consumers, it can effectively achieve the effect of 'peak shaving and valley filling' and reduce the cost of electricity. For MG operators, it can improve the consumption rate of renewable energy and increase revenue. [ABSTRACT FROM AUTHOR]

Development in economics and social society has led to rapid growth in electricity demand. Accurate residential electricity load forecasting is helpful for the transformation of residential energy consumption structure and can also curb global climate warming. This paper proposes a hybrid residential short-term load forecasting framework (DCNN-LSTM-AE-AM) based on deep learning, which combines dilated convolutional neural network (DCNN), long short-term memory network (LSTM), autoencoder (AE), and attention mechanism (AM) to improve the prediction results. First, we design a T-nearest neighbors (TNN) algorithm to preprocess the original data. Further, a DCNN is introduced to extract the long-term feature. Secondly, we combine the LSTM with the AE (LSTM-AE) to learn the sequence features hidden in the extracted features and decode them into output features. Finally, the AM is further introduced to extract and fuse the high-level stage features to achieve the prediction results. Experiments on two real-world datasets show that the proposed method is good at capturing the oscillation characteristics of low-load data and outperforms other methods. [ABSTRACT FROM AUTHOR]

The choice of an appropriate fuel can effectively prolong the refueling cycle of a reactor core. The Th-U cycle and U-Pu cycle are commonly used fuel breeding cycles. Oxide fuels, nitride fuels, and metal fuels are the primary candidate fuels for lead-based reactors. For fuel selection, a core model of a 60 MWt reactor was established. The results show that the breeding performance of the breeding fuel Th-232 is better than that of U-238, and the driving performance of the driving fuel Pu-239 is better than that of U-235. Therefore, PuO2-ThO2, PuN-ThN, and Pu-Th-Zr fuels may have good performance. By comparing the reactivity loss of three types of fuel, it was found that the reactivity loss of PuN-ThN fuel is the smallest. Hence, using PuN-ThN fuel as a core fuel can result in a longer refueling cycle. On this basis, PuN-ThN fuel was used in the preliminary design of the 120 MWt core physical model. It can be seen that when PuN-ThN fuel is used as the core fuel, a smaller reactivity swing (1408 pcm), smaller power peak factor, and super long refueling cycle (more than 30 years) can be obtained. [ABSTRACT FROM AUTHOR]

Summary: To address the issue of large inaccuracies in the low‐burnup region of aditonal machine learning algorithms for predicting nuclide density, the DRAGON code is used to produce 9600 samples using the nuclide densities of 235U, 239Pu, 241Pu, 137Cs, and 154Nd as prediction parameters. The mean square error (MSE) was used as the loss function for the deep neural network‐based nuclide density prediction model. The trained model is used to predict the target nuclides in the test set, and the relative error with the multilayer perceptron model are compared. The prediction results demonstrate that the deep neural network‐based prediction model not only overcomes the issue of excessive prediction errors in the low‐burnup region of the traditional machine learning algorithm model, but also has lower prediction errors in the medium‐burnup and high‐burnup regions, demonstrating the feasibility of artificial intelligence in nuclide density prediction. [ABSTRACT FROM AUTHOR]

Summary: Based on the failure of critical parameter sensors at nuclear power plants (NPPs) during accidents, a prediction model for critical parameter prediction during accidents was developed utilizing a long short‐term memory (LSTM) neural network and historical‐critical parameter operation sequences. The validation results show that the critical parameters model built with the LSTM neural network accurately predicts nuclear power, pressurizer pressure, pressurizer water level, coolant flow rate, coolant average temperature, and steam generator water level under loss of coolant accident and steam generator tube rupture conditions, and can help in the event of a sensor failure of critical operating parameters. This means that NPP operators will be able to better control the unit's status and improve safety in the event of a major operating parameter sensor failure. [ABSTRACT FROM AUTHOR]

Summary: Electrical fires caused by leakage, short circuit, overload, and other electrical failures occur frequently in residential areas, and failure to find and locate the fault location in time is the main reason for the evolution of circuit fault into electrical fire, especially in the ancient buildings with aging circuit facilities. Different from modern large‐scale buildings, ancient architectural complex is composed of a large number of scattered low buildings with inconsistent facility specifications and simple structure, so it does not have the conditions to deploy unified electrical lines and establish traditional large‐scale circuit monitoring system. In this study, we design an electrical fire monitoring IoT (EFM‐IoT) framework, which can realize early fire warning by monitoring the residual current of appliances and is easy to deploy in ancient buildings. EFM‐IoT adopts the data cleaning mechanism based on report form to filter redundant data, reducing computing and storage pressure in the cloud. Moreover, we analyze the energy consumption in the process of residual current and temperature data flow, and explore an effective energy‐saving mechanism for transmission. EFM‐IoT has been successfully applied in Chinese historical and cultural street—Pingjiang Road of Suzhou. Extensive evaluation and analysis results demonstrate that EFM‐IoT can effectively alleviate the data traffic and load in the cloud and reduce the response time of early warning. [ABSTRACT FROM AUTHOR]

Introduction: As standard care of severe haemophilia A (SHA), prophylaxis should be individualised. Aim: This study aimed to investigate the effectiveness of this new‐proposed individualised prophylaxis protocol. Methods: Boys with SHA were enrolled and followed a PK‐guided, trough‐level escalating protocol of prophylaxis after a six‐month observational period. In the next 2 years, clinical assessments including joint bleeds, ultrasound (US) scores and Haemophilia Joint Health Score (HJHS) in both sides of ankles, knees and elbows were conducted every 6 months as a scoring system, which determined whether the trough level's escalation. Adjustment of dosing regimen was based on WAPPS‐Hemo. Results: Fifty‐eight SHA boys were finally analysed. Their age and bodyweight were 5.3(2.8,6.9) years and 21.5(16,25) kg. During the study, 47 escalations were conducted. At study exit, the patient number and proportion of different trough level groups were: < 1 IU/dl, 17.2% (10/58); 1–3 IU/dl, 53.5% (31/58); 3–5 IU/dl, 15.5% (9/58); > 5 IU/dl, 13.8% (8/58). Significantly reduced annualised bleeding rate [4(0,8) to 0(0,2), p <.0001] and annualised joint bleeding rate [2(0,4) to 0(0,.25), p <.0001] was observed at study exit as well as the continuous trend of increased zero bleeding proportion (ZBP) (27.6%–69.0%) and zero joint bleeding proportion (46.5%–81.3%). Besides, 85% (6/7) of the target joints vanished. Statistical improvements of US scores (p =.04) and HJHS (p =.02) were also reported at study exit. Conclusion: Our results showed the effectiveness of our protocol based on individualised target trough level and emphasise the importance of personalised prophylaxis. [ABSTRACT FROM AUTHOR]

The 3D chromatin structure within the nucleus is important for gene expression regulation and correct developmental programs. Recently, the rapid development of low-input chromatin conformation capture technologies has made it possible to study 3D chromatin structures in gametes, zygotes and early embryos in a variety of species, including flies, vertebrates and mammals. There are distinct 3D chromatin structures within the male and female gametes. Following the fertilization of male and female gametes, fertilized eggs undergo drastic epigenetic reprogramming at multi levels, including the 3D chromatin structure, to convert the terminally differentiated gamete state into the totipotent state, which can give rise to an individual. However, to what extent the 3D chromatin structure reorganization is evolutionarily conserved and what the underlying mechanisms are for the tremendous reorganization in early embryos remain elusive. Here, we review the latest findings on the 3D chromatin structure reorganization during embryogenesis, and discuss the convergent and divergent reprogramming patterns and key molecular mechanisms for the 3D chromatin structure reorganization from gametes to embryos in different species. These findings shed light on how the 3D chromatin structure reorganization contribute to embryo development in different species. The findings also indicate the role of the 3D chromatin structure on the acquisition of totipotent developmental potential. [ABSTRACT FROM AUTHOR]

Introduction: Development of haemophilia B inhibitors (HBI) results in the ineffectiveness of FIX replacement therapy. Inhibitor eradication by immune tolerance induction (ITI) is therefore necessary. In HBI, ITI even at high FIX dose is less effective and has a higher risk of severe complications. Aim: To characterize clinical features and outcome of ITI on HBI. Methods: This retrospective study was conducted in Haemophilia Paediatric Comprehensive Care Centre of China. We used low‐dose ITI (25–50 FIX IU/kg/three‐times‐weekly to every‐other‐day) with domestic prothrombin complex concentrate (PCC), combined with two successive immunosuppressive (IS) regimens. Results: Sixteen HBI children, representing 5.7% of all and 14.4% of our severe registered HB patients, were enroled. Seven cases reported allergic reactions (ARs) proximal to inhibitor development. The historic peak inhibitor titre was median 54.2 (range 4.7–512) BU, and 15 (93.8%) had high‐titre inhibitors. Twelve patients adherent to ITI were analysable. Of the nine ITI patients who received rituximab/prednisone (IS Regimen‐1), four achieved tolerization in 1.4–43.3 months. Two subsequently relapsed but re‐tolerized after a second course of IS Regimen‐1. During ITI, the median treated bleed was.39/month (82.7% reduction from before ITI), and the incidence of AR and nephrotic syndrome (NS) complications was each at 22% (2/9). Three ITI patients received modified 'Beutel' protocol (IS Regimen‐2) using multiple‐IS‐drugs, and two had rapid tolerization (.8 and 1.8 months). Conclusions: Inhibitor eradication could be achieved by low‐dose ITI protocol using PCC combined with IS. Larger studies are needed to confirm if ITI with IS Regimen‐2 is more effective with less complications. [ABSTRACT FROM AUTHOR]

Allergic reactions to FIX have been associated with nephrotic syndrome and poor ITI outcome.3 Both our cases did, with case 2 having allergic reactions simultaneously with inhibitor development. This is consistent with previous observations that NS development was closely related to a significant decline in inhibitor titre.2 Interestingly, the NS in case 2 was preceded by a second allergic reactions to the ITI regimen and in case 1 by a fluctuation of inhibitor titres during ITI-rituximab. Patients with haemophilia B (HB) may develop factor IX (FIX) inhibitors with a cumulative incidence of 10.2% following FIX replacement therapy by 500 exposure days.1 In 50-60% cases, occurrence of severe allergic reactions may precede or occur simultaneously with the inhibitor development.2 The propensity for FIX to induce allergic reactions (compared to FVIII) may be related to the extravascular distribution of the smaller FIX molecules.3 Immune tolerance induction (ITI) therapy to eradicate FIX inhibitors has a poor success rate of only 13-31%.2,4 There is also a risk of developing nephrotic syndrome (NS) in 17-33% cases. Nephrotic syndrome in two haemophilia B children with inhibitor under low-dose immune tolerance induction combined with rituximab-based immunosuppressant protocol. [Extracted from the article]

Background: Drug-induced thrombocytopenia (DITP) is a severe adverse reaction and a significantly under-recognized clinical problem in children. However, for post-marketing pharmacovigilance purposes, detection of DITP signals is crucial. This study aimed to develop a signal detection model for DITP using the pediatric electronic medical records (EMR) data. Methods: This study used the electronic medical records collected at Beijing Children's Hospital between 2009 and 2020. A two-stage modeling method was developed to detect the signal of DITP. In the first stage, we calculated the crude incidence by mining cases of thrombocytopenia to select the potential suspected drugs. In the second stage, we constructed propensity score–matched retrospective cohorts of specific screened drugs from the first stage and estimated the odds ratio (OR) and 95% confidence interval (CI) using conditional logistic regression models. The novelty of the signal was assessed by current evidence. Results: In the study, from a total of 839 drugs, 21 drugs were initially screened as potentially inducing thrombocytopenia. In total, we identified 18 positive DITP associations. Of these, potential DITP risk of nystatin (OR: 1.75, 95% CI: 1.37–2.22) and latamoxef sodium (OR: 1.61, 95% CI: 1.38–1.88) were two new DITP signals in both children and adults. Six associations between thrombocytopenia and drugs including imipenem (OR: 1.69, 95% CI: 1.16–2.45), teicoplanin (OR: 4.75, 95% CI: 3.33–6.78), fusidic acid (OR: 2.81, 95% CI: 2.06–3.86), ceftizoxime sodium (OR: 1.83, 95% CI: 1.36–2.45), ceftazidime (OR: 2.16, 95% CI: 1.58–2.95), and cefepime (OR: 5.06, 95% CI: 3.77–6.78) were considered as new signals in children. Conclusion: This study developed a two-stage algorithm to detect safety signals of DITP and found eighteen positive signals of DITP, including six new signals in a pediatric population. This method is a promising tool for pharmacovigilance based on EMR data. [ABSTRACT FROM AUTHOR]

Chronic immune thrombocytopenia (CITP) is an autoimmune disease with many immune dysfunctions, including T helper type 17 cell (Th17)/regulatory T cells (Tregs) imbalance. Low quality of life and side effects of drugs are severe, especially in pediatrics. This study aimed to determine Th17/Treg polarization in pediatric CITP when first diagnosing ITP and evaluate its use as a predictive marker for pediatric CITP. This was a pilot study from a multi-center. Setting the effective data size to 100 patients, data entry ended in the 142nd patient who had completed a 1-year follow-up. The percentages of Treg cells and Th17 cells were quantified by flow cytometry when new diagnosed ITP patients first arrived. The association between the Th17/Treg ratio and CITP was analyzed statistically. The percentages of Treg cells and Th17 cells were lower (P = 0.0008) and higher (P = 0.0001), respectively, in the CITP-outcome group compared with the remission group. The receiver operating characteristic analysis showed that the area under the curve (AUC) of Treg and Th17 cells was 0.811 and 0.834, respectively. The ratio of Th17/Treg exhibited the largest AUC of 0.897 (cutoff value 0.076). Conclusions: Thus, the percentage of Th17 /Treg ratio of pediatric CITP is elevated at new diagnosed ITP stage. It is a promising predictive marker for the development of CITP to some extent. Trial registration: ChiCTR1900022419 (10th April 2019) What is Known: • The percentage of Th17 /Treg ratio of pediatric CITP is elevated. What is New: • This study shows that the percentage of Th17 /Treg ratio of pediatric CITP is elevated at new diagnosed ITP stage. This work may provide a new point for pediatric CITP's prediction. The imbalanced ratio of Th17/Treg was obvious when first diagnose ITP in pediatric CITP patients, rendering them as potential predictive tools for discriminating CITP to facilitate with the management of pediatric patient care. In addition, the combination of them may serve as a predictive marker in pediatric CITP. [ABSTRACT FROM AUTHOR]

Interactions between proteinaceous matter and atmospheric oxidants can affect amino acids (AAs) bioavailability, the climate, and human health. However, atmospheric reactions of proteinaceous matter remain poorly understood. PM2.5 samples were collected during spring (2019) and winter (2020) sampling campaigns conducted in Nanchang, China. Concentrations of combined and free AAs, and the δ15N values of combined and free glycine (C‐Gly and F‐Gly) in PM2.5 samples were analyzed. Concentrations of TFAA under different O3 and NO2 levels, and correlations of specific FAA species with ambient O3 and NO2 concentrations suggest that the ability of O3 to release TFAA from proteinaceous matter is greater than that of NO2. Furthermore, O3 may trend to release neutral and hydrophilic FAA species, whereas NO2 tends to generate hydrophobic FAA species. With aerosol aging, the slope of the fitted line between [TFAA] and [TSAA] [O3 + NO2] increased, indicating that FAAs yield from protein degradation in PM2.5 was affected greatly by aerosol aging. The TCAAs concentration observed in spring was substantially higher than that in winter. Moreover, the δ15NF‐Gly and δ15NC‐Gly values in PM2.5 exhibited negative correlations with atmospheric O3 concentration. These results suggest that increased levels of proteinaceous matter in spring were derived from natural sources related to biological activities rather than biomass burning sources. Our study confirms that the reaction of degradation of proteinaceous matter to FAAs could be influenced by aerosol aging, which is a finding that enhances current understanding regarding atmospheric processes of aerosol proteinaceous matter under different ambient O3 and NO2 levels. Key Points: Ability of O3 to release TFAA from proteinaceous matter is greater than that of NO2O3 might trend to release neutral and hydrophilic free amino acids (FAA) species, whereas NO2 tends to generate hydrophobic FAA speciesYield of FAAs from the degradation of protein in PM2.5 samples was affected greatly by the degree of aerosol aging [ABSTRACT FROM AUTHOR]

Background: The traditional weight‐based dosing regimen can lead to under‐ or overdosage due to the interindividual variability of pharmacokinetic (PK) parameters. PK‐guided prophylaxis can be an optimized therapy choice. Aim: This study aimed to investigate the clinical outcomes of PK‐guided prophylaxis in 46 boys with severe haemophilia A. Methods: Forty‐six boys with severe haemophilia A were enrolled in Beijing Children's Hospital. The PK tests were performed using a five‐point assay. PK parameters were calculated using WinNonlin software. The dosing regimen and bleeding rates recorded during the observation period. The adjustment was based on PK evaluation, bleeding details, doctor's advice and patients' choice. Results: The half‐life time, in vivo recovery and clearance of Kovaltry were 14.34 ± 2.68 h, 1.78 ± 0.29 kg/dl and 3.38 ± 0.94 ml/kg/h, respectively. In 18 patients without any change in the dosing regimen, the trough level was 4.0 ± 2.41 IU/dl and the bleeding rates were similar after PK tests. For patients with a higher trough level after adjustment, higher dose and frequency were observed, as well as a higher trough level. Also, reduced annual bleeding rate (ABR), annual joint bleeding rate and annual spontaneous bleeding rate (ASBR) were found. In five patients with a reduced trough level, lower infusion frequency and weekly coagulation factor VIII (FVIII) consumption were observed, with no statistically significant difference in ABR and ASBR. Conclusion: PK‐guided prophylaxis can help haemophiliac patients improve quality of life by decreasing bleeds with appropriate FVIII consumption and reducing infusion frequency without increments in bleeds, thus optimizing haemophilia treatment. [ABSTRACT FROM AUTHOR]

A low-dose immune tolerance induction (ITI) protocol incorporating immunosuppressive agents in haemophilia A children with high-titre factor VIII inhibitor and poor-ITI prognostic risk These were all on good-ITI risk patients with inhibitor titre <10 BU at the initiation of ITI and historical peak inhibitor titre <200 BU. Nineteen haemophilia A inhibitor children with poor-ITI risk (historical peak inhibitor titre >=100 BU and/or inhibitor titre >=40 BU at ITI initiation) (Table 1) were enrolled from September 2016 through April 2019. Various ITI regimens achieved an overall success rates of 60%-80%.2,3 According to the UK guideline,4 low-dose ITI (50 IU/kg, every-other-day) was only suggested for using in patient with low-titre inhibitors (historical peak inhibitors <5 BU). [Extracted from the article]

The defect characteristic and magnetic properties of CuFe1-xCrxO2 (x = 0.0–0.4) compounds have been investigated in detail. The results demonstrate that Cr3+ ions enter into the CuFeO2 lattice sites and induce local lattice contraction but do not change the valance state of Cu+ and Fe3+ ions. We calculate the positron annihilation lifetime in the bulk and vacancy defect trapping states by the atomic superposition method in 3 × 3 × 1 CuFeO2 super-cell. Combined with theoretical calculation results, the positron annihilation results indicate that the positrons are mainly annihilated in vacancy clusters in CuFe1-xCrxO2. The substitution of Cr3+ for Fe3+ ions decreases the open volume and increases the concentration of vacancy defects but does not change the integral defect surroundings at annihilation sites. Magnetization measurements manifest that doping with Cr3+ reduces the antiferromagnetic transition temperature and promotes the formation of short-range magnetic correlation. Meanwhile, the enhanced short-range magnetic correlation in Cr3+-doped CuFeO2 is more readily driven by thermal activation energy and a faster dynamic behavior can be seen in time windows. [ABSTRACT FROM AUTHOR]

Background: Kovaltry (BAY81‐8973) is an unmodified full‐length factor VIII (FVIII) concentrate that enhances the pharmacokinetic (PK) profiles as compared to some other standard half‐life time FVIII concentrates. However, the PK of Kovaltry in haemophiliac patients aged <12 years has not been reported previously. Aim: To investigate the pharmacokinetics and clinical outcomes of Kovaltry in 35 paediatric patients aged <12 years. Methods: A total of 35 boys with severe haemophilia A were enrolled from August 2019 to May 2020 in Beijing Children's Hospital. After 72‐hour washout, PK tests were performed post‐infusion of 50 IU/kg Kovaltry in a five‐timepoint assay. WinNonlin software was used to generate individual PK parameters. The dose, frequency and bleeding details were collected within the first 6 months after switching to Kovaltry from other FVIII concentrates. Results: Compared to the blood group O, patients with blood group non‐O showed longer mean half‐life (t1/2) (p <.01), lower mean clearance (CL) (p =.01) and similar in vivo recovery (IVR) (p =.51). Higher von Willebrand factor antigen (VWF:Ag) level was correlated to longer t1/2 (p <.0001) and lower CL (p <.01). IVR was correlated to body mass index (BMI) (p <.0001). Patients with trough level >3 IU/dL demonstrated lower annual bleeding rate (ABR) (p <.01), annual joint bleeding rate (AJBR) (p <.01) and annual spontaneous bleeding rate (ASBR) (p <.01). Conclusion: This study firstly reported the PK profiles of Kovaltry in 35 paediatric patients <12 years old. The great inter‐individual variability of PK parameters was also confirmed in these patients. VWF:Ag and blood group were major influencing factors of t1/2 and CL of Kovaltry, while BMI was a vital predictor for IVR. Patients with high trough FVIII level in routine prophylaxis had reduced bleeding rates. [ABSTRACT FROM AUTHOR]

In this paper, M (Sc3+ and Zr4+)-doped CuFeO2 ceramics were prepared by using a solid-state reaction method. The effects of isovalent Sc3+ and nonisovalent Zr4+ substitution on the structure, defects, optical, and magnetic properties of CuFeO2 ceramics are comparatively investigated. The results demonstrated that all of the obtained samples are well crystallized, and M substitution leads to lattice structure distortion. The average grain sizes reduce with the addition of M. Positron annihilation lifetime results indicate that the vacancy clusters are present in all samples, and the Zr-substituted CFO sample has the maximum open volume and concentration of the defect among those three samples. Furthermore, the bandgap of the M-substituted samples becomes wider due to the broad bandgap of Sc2O3 and ZrO2. M substitution enhances the Urbach energy (EU) values in CFO system, which is in good consistent with the dependences of the defect concentration on the substitution elements. The magnetic measurements reveal that Sc and Zr substitution decrease the magnetic temperatures TN1 and TN2, which may be attributed to the consequence of the magnetic dilution effect and the change in the strength of exchange interaction. In addition, the defects are of major importance for regulating the magnetic properties of CFO ceramics. [ABSTRACT FROM AUTHOR]

Comparative pharmacokinetics of Kogenate FS and Kovaltry in 14 Chinese paediatric patients with haemophilia A: A single-centre study Although the CL of Kogenate FS and Kovaltry showed no statistical difference in our study, the CL of Kovaltry showed a decreasing trend when compared with Kogenate (3.35 vs 3.78 mL/kg/h). Keywords: factor VIII; haemophilia A; haemorrhage; paediatric patients; pharmacokinetics EN factor VIII haemophilia A haemorrhage paediatric patients pharmacokinetics e287 e290 4 03/23/21 20210301 NES 210301 Dear Editor, Haemophilia A is an X-linked inherited bleeding disease caused by a deficiency in the activity of coagulation factor VIII (FVIII). According to the World Federation of Hemophilia (WFH), the management of haemophilia A involves prophylaxis as standard of care, especially for patients with severe haemophilia A.1 However, significant interindividual variability is observed within the patients of haemophilia A in response to treatment. [Extracted from the article]

Importance: The use of factor VIII (FVIII) concentrates under pharmacokinetic (PK) guidance has become the main approach for treatment of hemophilia. However, limited PK research has been conducted in Chinese pediatric patients. Objective: To investigate the PK parameters of various FVIII concentrates in Chinese pediatric patients. Methods: Seventy‐nine patients were enrolled (28 treated with Kogenate FS®, 23 treated with Advate ®, and 28 treated with GreenMono™). All enrolled patients participated in single‐dose PK analysis after at least a 3‐day washout period. Blood samples were collected predose, as well as at 1 h, 9 h, 24 h, and 48 h after infusion; FVIII levels were measured using a one‐stage clotting assay. von Willebrand Factor Antigen (VWF:Ag) levels and blood types were also determined. PK parameters were evaluated by WAPPS‐Hemo. Results: Mean values of terminal elimination half‐life time (t1/2) for the Kogenate FS®, Advate®, and GreenMono™ FVIII groups were 12.24 h, 10.18 h, and 9.62 h; median clearance values were 4.16, 6.23, and 5.11 mL·kg−1·h−1; and median in vivo recovery values were 1.97, 1.55, and 1.61 IU/dL per IU/kg. Longer t1/2, higher in vivo recovery, and lower clearance were observed in patients with higher VWF:Ag level who were treated with recombinant concentrates. Interpretation: Chinese pediatric patients with hemophilia had FVIII PK characteristics similar to those previously observed in non‐Chinese children, including large variation among individuals. VWF:Ag level and FVIII brand were associated with differences in FVIII PK. Thus, PK‐guided dosing should be used to optimize individualized therapy in Chinese children. [ABSTRACT FROM AUTHOR]

Amino acids (AAs) are relevant for nitrogen cycles, climate change and public health. Their size distribution may help to uncover the source, transformation and fate of protein in the atmosphere. This paper explores the use of compound-specific δ15 N patterns of hydrolyzed amino acid (HAA), δ15 N values of total hydrolyzed amino acid (δ15 N THAA), degradation index (DI) and the variance within trophic AAs (∑V) as markers to examine the sources and processing history of different sizes of particle in the atmosphere. Two weeks of daily aerosol samples from five sampling sites in the Nanchang area (Jiangxi Province, China) and samples of main emission sources of AAs in aerosols (biomass burning, soil and plants) were collected (Zhu et al., 2020). Here, we measured the concentrations and δ15 N values of each HAA in two size-segregated aerosol particles (> 2.5 µ m and PM 2.5). Our results showed that the average concentrations of THAA in fine particles was nearly 6 times higher than that in coarse particles (p < 0.01) and composition profiles of fine and coarse particles were quite different from each other. The δ15 N values of hydrolyzed glycine and THAA in both fine and coarse particles were typically in the range of those from biomass burning, soil and plant sources. Moreover, the average difference in the δ15 N THAA value between fine and coarse particles was smaller than 1.5 ‰. These results suggested that the sources of atmospheric HAAs for fine and coarse particles might be similar. Meanwhile, compared to fine particles, significantly lower DI values (p < 0.05), "scattered" δ15 N distribution in trophic AA and higher ∑V values (p < 0.05) were observed in coarse particles. But the difference in δ15 N values of source AA (glycine, serine, phenylalanine and lysine) and THAA between coarse particles and fine particles was relatively small. It is likely that AAs in coarse particles have advanced bacterial degradation states compared to fine particles. Besides that, the significant increase in DI values and a decrease in ∑V values for coarse particles were observed on days on which precipitation fell (p < 0.05). This implies that "fresh" AAs in coarse particles were likely released following the precipitation. [ABSTRACT FROM AUTHOR]

Data outsourcing has gradually become a mainstream solution, but once data is outsourced, data owners will without the control of the data hardware, there is a possibility that the integrity of the data will be destroyed objectively. Many current studies have achieved low network overhead cloud data set verification by designing algorithmic structures (e.g., hashing, Merkel verification trees); however, cloud service providers may not recognize the incompleteness of cloud data to avoid liability or business factors fact. There is a need to build a secure, reliable, non-tamperable, and non-forgeable verification system for accountability. Blockchain is a chain-like data structure constructed by using data signatures, timestamps, hash functions, and proof-of-work mechanisms. Using blockchain technology to build an integrity verification system can achieve fault accountability. Blockchain is a chain-like data structure constructed by using data signatures, timestamps, hash functions, and proof-of-work mechanisms. Using blockchain technology to build an integrity verification system can achieve fault accountability. This paper uses the Hadoop framework to implement data collection and storage of the HBase system based on big data architecture. In summary, based on the research of blockchain cloud data collection and storage technology, based on the existing big data storage middleware, a large flow, high concurrency and high availability data collection and processing system has been realized. [ABSTRACT FROM AUTHOR]

The polycrystalline CuFeO2 (CFO) and CuFe1-xMxO2 (M = Ti, Hf, Zr, M-CFO) samples are synthesized by solid-state reaction method. The doping effect of tetravalent nonmagnetic transition metal M4+ ions on the microstructure, defect evolution, and magnetic and magnetocaloric properties of the CFO system are comparatively investigated. The substitution of M4+ for Fe3+ increases lattice parameters, changes the bond length of Fe/Cu-O and bond angle of Fe-O-Fe, and improves the microstructure to some extent. Positron annihilation spectroscopy results indicate that M4+ doping induces the agglomeration of small-sized vacancy defects manifested as the increase in vacancy-type defect size and the suppression of inherent defect concentration. Magnetic measurements show that the antiferromagnetic stability of CFO system is clearly affected by M4+ doping, and Ti4+ doping has a more noticeable impact than Hf4+ and Zr4+ doping. Meanwhile, the coexistence of weak ferromagnetism and antiferromagnetism is detected in all doped samples, while Ti-doped system exhibits extraordinary magnetic properties. Especially for Ti-CFO2 (x = 0.03) sample, the maximum magnetization reaches as high as 11.81 emu/g at 0.5 T, which enhanced one order of magnitude than that of undoped CFO. Isothermal M-H data at different temperatures show that entropy change (ΔSM) and refrigerant capacity (RC) for CFO and M-CFO2 samples are significantly weakening with M4+ substitution in bulk CFO. The maximum ΔSM = 4.79 J·kg−1 K−1 and RC = 12.79 J·kg−1 for undoped CFO are obtained near the transition temperature TN2 = 12 K, with the applied fields up to 6 T. The possible reasons for the above observations are discussed in detail. [ABSTRACT FROM AUTHOR]

GdMnO3 (GMO) ceramics were prepared by solid-state reaction method, the structure, defects, dielectric, and magnetic properties of GMO ceramics sintered at different temperatures have been studied. Characterization by XRD indicates that impurity phase-free GMO can be synthesized at 1350 °C. SEM measurements show that the grain size of GMO increases and the microstructure becomes denser with increasing sintering temperature. Positron annihilation results reveal that the vacancies concentration decreases when sintering temperature increases from 1300 to 1350 °C, and then increases when sintering temperature increases from 1350 to 1400 °C. Dielectric measurements indicate that the GMO ceramic sintered at 1350 °C presents higher dielectric constant and smaller dielectric loss. Magnetic properties measurements show that the magnetic properties of GMO can be modulated by sintering temperature. The relation between structure and properties implies that the cation vacancy defect has remarkable effects on the dielectric and magnetic properties of GMO. [ABSTRACT FROM AUTHOR]

Objective: This study aims to investigate the association of circulating T follicular helper (cTfh) cells and T follicular regulatory (cTfr) cells with acute myeloid leukemia (AML) patients. Methods: A total of 22 newly diagnosed, untreated AML patients as well as 26 healthy controls were enrolled. Percentages of cTfh and cTfr cells were detected using flow cytometry. Results: Compared to healthy controls, a significantly higher percentage of cTfr cells was observed in AML patients (4.10 ± 11.18 vs. 0.63 ± 0.38%) (p < 0.05). In addition, a significantly lower cTfh/cTfr ratio was found in the AML patients' group when compared to the control group (9.04 ± 9.19 vs. 11.66 ± 5.68) (p < 0.05). A lower level of plasma IL-2 and TGF-β1 was found in AML patients. Based on the complete remission (CR) response after one cycle of inductive chemotherapy, patients were divided into two groups at sample collection: AML with and without CR. Significantly lower percentages of cTfr cells and a higher cTfh/cTfr ratio were found in the group of AML patients with CR than in the AML patients without CR. Conclusion: There was a significantly higher percentage of cTfr cells in AML patients. cTfr cells may have a potential association with the pathogenesis of AML patients. [ABSTRACT FROM AUTHOR]